Acrongenomics Inc. (OTCBB:AGNM) announces today that it has appointed London based De Facto Communications to manage its public and investor relations from January 2008. De Facto’s...
Acrongenomics Inc. (OTCBB:AGNM) announced today that it has signed a letter of intent for the acquisition of 100% of Molecular Vision Limited, (“Molecular Vision”) a private U.K. company that...
GENEVA--(BUSINESS WIRE)--Acrongenomics, Inc. (OTCBB:AGNM) and Molecular Vision, Ltd. (“MVL”) -- an Imperial College spin-out company -- are pleased to announce the...
GENEVA--(BUSINESS WIRE)--Acrongenomics, Inc. (OTCBB:AGNM) and Molecular Vision, Ltd (MVL). -- an Imperial Innovations spin-out company are pleased to announce today that due to the...
GENEVA--(BUSINESS WIRE)--Acrongenomics, Inc. (OTCBB:AGNM) and Molecular Vision, Ltd (MVL). -- an Imperial Innovations spin-out company -- today announce that a demonstration version of...
GENEVA--(BUSINESS WIRE)--Acrongenomics, Inc. (OTCBB:AGNM)
and Molecular Vision, Ltd. -- an Imperial Innovations spin-out company
-- today present a third R&D update of their joint...
GENEVA--(BUSINESS WIRE)--Acrongenomics, Inc. (OTCBB:AGNM) and Molecular Vision, Ltd. -- an
Imperial Innovations spin-out company -- today present a second R&D
update of their...
#2: AGNM News Molecular Vision, Pearson Matthews, Acrongenomics and Imperial College London Secure GBP 440,000 (US $825,000) Award from the UK National Health Service
GENEVA--(BUSINESS WIRE)--Sept. 15, 2006--Molecular Vision Ltd in partnership with Acrongenomics, Inc. (OTCBB:AGNM), Pearson Matthews Ltd, and Imperial College London has today been awarded GBP...
GENEVA, Switzerland--(BUSINESS WIRE)--July 31, 2006--Acrongenomics, Inc. (OTCBB:AGNM) and Molecular Vision, Ltd. -- an Imperial Innovations spin-out company -- today present an R&D update of their...